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Malignant melanoma is the leading cause of death among skin cancers in western
countries. The incidence of cutaneous melanoma has increased more than tenfold
over the last fifty years and its incidence is increasing more rapidly than any other
malignancies in Caucasian populations.1 Exposure to ultraviolet rays of the sun is
known to be an important risk factor for developing cutaneous melanoma.2 There-
fore, cutaneous melanoma is largely considered to be a disease of fair skinned,
blue-eyed individuals in latitudes with increased sun exposure. However, in Asian
populations, there are only a few published reports since the incidence is much
lower.3-8 Cutaneous melanomas in non-Caucasian populations are frequently
manifested differently than in Caucasian populations. In comparison to the cut-
aneous melanomas arising in Caucasians, they occur more commonly in unusual
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Purpose: A retrospective study was conducted to review the treatment and out-
comes of mainly melanomas in acral location in a single institution in Korea, and
to evaluate the prognostic significance of anatomic locations of the tumor. Materials
and Methods: A retrospective review was completed on 40 patients between
2001 and 2006 to obtain pertinent demographic data, tumor data, treatment charac-
teristics, and follow-up data. Results: Forty melanoma patients were identified
and analyzed. Of these, 18 were male and 22 were female patients and the mean
age at the time of diagnosis was 55.9 years. Of the tumors, 65% were located on
the hands and feet with acral lentiginous melanoma being the most common
histological subtype. Univariate analysis for the overall melanoma survival revealed
that the thickness of the tumor and the clinical stage have prognostic significances.
The most significant factor as analyzed by a multivariate analysis was shown to be
the advanced clinical stage. Acral melanomas did not show statistically significant
differences in the age at diagnosis, thickness of the tumor, stage, ulceration, and
survival rates compared to non-acral melanomas. There was also no significant
difference in the survival rate between the patients treated by amputation versus
wide local excision in acral melanomas. Conclusion: In Korean melanoma
patients, thickness and advanced stages are significant factors for poorer prognosis.
However, the location of melanoma did not have a significant prognostic value. In
treating the melanomas in acral location, local wide excisions resulted in a similar
prognosis compared to amputations.
Key Words: Melanoma, acral locations, prognosis, treatment 
Received: May 26, 2009
Revised: October 19, 2009
Accepted: November 4, 2009
Corresponding author: Dr. Kee Yang Chung,
Department of Dermatology and Cutaneous
Biology Research Institute, Yonsei University
College of Medicine, 250 Seongsan-ro,
Seodaemun-gu, Seoul 120-752, Korea.
Tel: 82-2-2228-2080, Fax: 82-2-393-9157
E-mail: kychung@yuhs.ac
∙The authors have no financial conflicts of
interest.
© Copyright:
Yonsei University College of Medicine 2010
This is an Open Access article distributed under the
terms of the Creative Commons Attribution Non-
Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted non-
commercial use, distribution, and reproduction in any
medium, provided the original work is properly cited.
INTRODUCTION
sites (e.g., hands and feet) in the form of acral melano-
mas.3-6 Due to the rarity of their occurrences and acral
presentations, diagnosis is often delayed resulting in more
advanced stages of disease at presentation.9 Cutaneous
melanoma is frequently curable with simple wide surgical
excision when diagnosed at an early stage. As a result,
efforts to enhance early diagnosis by educational programs
represent one of the primary strategies to improve outcomes.
It is generally believed that melanomas arising in acral
locations may be initially diagnosed at a more advanced
stage and it may account for the grave prognosis.9 However,
it is unclear whether the worse prognosis of melanomas
arising in hands and feet is due to a delay in diagnosis or the
disease being a biologically distinct entity, or a combina-
tion of both. To confirm this issue, we reviewed our experi-
ence in the management of cutaneous melanomas patients
in a single institution in Korea by dividing them according
to the anatomic sites of acral and non-acral locations.
Study population
The computerized database in the dermatology department
of Yonsei University Health System in Seoul, Korea was
used for the study. There were 48 patients diagnosed as
malignant melanoma in the dermatology department from
2001 to 2006. However, 5 patients with insufficient data
and 3 patients with metastatic melanoma with an unknown
primary origin were excluded in the analysis. The age of
onset, duration of lesion until diagnosis, sex, site, histologic
subtype, Breslow thickness, presence of ulceration, clinical
staging [American Joint Committee on Cancer (AJCC)
2002],10 treatment method, and survival (from the date of
histologic diagnosis to the date of last follow-up or death)
were extracted for the analysis. 
Statistical analysis
The method of Kaplan and Meier was used to calculate sur-
vival curves, and significant differences were determined by
the log-rank test. Univariate analysis was used to calculate
the relative risk of each parameter and multivariate analyses
of prognostic variables were performed using Cox regres-
sion model and the t-test analysis was used when appro-
priate. A p value less than 0.05 was considered significant.
Patient characteristics
A total of 40 patients with cutaneous melanoma were anal-
yzed in this study. Of these, 18 were men and 22 were
women; the mean age was 55.9 years (range, 29-79 years)
(Fig. 1). The mean duration of lesion until time of diagnosis
was 6.2 years (range, 0.2-40 years). Hands and feet were
the most commonly involved locations, with 65% of the
patients having primary tumors at these sites. The mean
tumor thickness was 3.15 mm and the local tumor (stage I
and II) comprised 87.5%. Acral lentiginous melanoma
(ALM) was the most common histological subtype (26/40,
65%), followed by nodular melanoma (NM) (7/40, 17.5%),
lentigo maligna melanoma (5/40, 12.5%), and superficial
spreading melanoma (2/40, 5%). The mean ages of the
patients in each subtype were 55, 53, 56, and 59 years, res-
pectively. The mean Breslow thickness of the tumors was
also recorded (Table 1).  
Characteristics of patients with melanoma in acral 
location 
Table 2 summarizes the clinical characteristics of the mela-
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MATERIALS AND METHODS
RESULTS
Table 1. Subtypes of Melanoma
Subtype Case No. (%)
Age (yrs)
Sex M : F
Location* Breslow thickness 
mean I II III IV V VI (mm)
SSM 2 (5) 55 0 : 2 1 1 0.65 
LMM 5 (12.5) 53 4 : 1 5 0.90 
ALM 26 (65) 56 8 : 18 1 4 21 3.28 
NM 7 (17.5) 59 6 : 1 1 3 2 1 5.00 
Total 40 (100) 55.9 18 : 22 6 3 2 3 4 22 3.15 
SSM, superficial spreading melanoma; LMM, lentigo maligna melanoma; ALM, acral lentiginous melanoma; NM, nodular melanoma.
*Location I, head and neck; II, upper limbs; III, lower limbs; IV, trunk; V, hands / finger; VI, feet / toe.
Fig. 1. Distribution of cutaneous melanoma by age.
noma according to the location. The locations were divid-
ed into two groups which are melanoma arising in acral
locations, such as hand, foot, fingernail, and toenail, and
non-acral locations. Twenty-six melanomas were located
on acral locations. In these cases, there were more women
than men (men : women ratio, 1 : 2.7). Subtypes of the
melanoma occurring in this location were acral lentiginous
melanoma in 18 cases, subungal melanoma in 7 cases, and
nodular melanoma in one case on the dorsum of the foot.
The sole (57.7%) was the most common location among
the acral subtype (Table 3). The incidence of ulceration
was not significantly different compared to non-acral
locations. Age at the time of diagnosis was not statistically
different between the two groups. Also, the thickness of
the tumor and the mean stage were not statistically dif-
ferent between the two groups. The duration of the lesion
until the time of diagnosis of melanomas in acral locations
was 8.2 years and 2.5 years for melanomas in non-acral
locations. However, they were statistically insignificant
(Table 2).  For the treatment, 7 patients (4 subungal mel-
anomas, 2 melanomas on sole, 1 melanoma on heel) were
treated by amputation and the others (n = 19) by local wide
excision with safety margins determined according to the
thickness of the tumor. The mean tumor thickness of the
group treated with wide excision was 2.76 mm and 4.11
mm in the group treated with amputation. However, the
difference was not statistically significant (p = 0.256). The
mean stage of the group treated with wide excision was
1.82 and 1.86 in the group treated with amputation. This
difference was also statistically insignificant (p = 0.919).
Overall survival and prognosis
With univariate analysis, thicker tumors (> 2 mm) and clini-
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Table 2. Characteristics of Melanoma According to Anatomic Location
Factor Acral Non-acral p value
Case no. (%) 26 (65) 14 (35)
Age (yrs)
Range 32 - 78 29 - 77 0.78
Mean 55.5 56.7
Sex
Female 19 3
Male 7 11
Disease duration (yrs) 8.2 2.5 0.154
Ulceration
Yes 5 (27) 4 (13) 0.034
Disease duration (yrs) 8.2 2.5
Histologic subtype
SSM 0 2
LMM 0 5
ALM 18 1
NM 1 6
Subungal melanoma 7 6
Thickness 3.12 3.19 0.938
Stage at diagnosis 
0 2 2
I 9 4
II 13 5
III 1 3
IV 1 0
Mean 2.78 2.92 0.798
SSM, superficial spreading melanoma; LMM, lentigo maligna melanoma; ALM, acral lentiginous melanoma; NM, nodular melanoma.
Table 3. Specific Locations of Acral Melanoma
Location Case no. (%)
Sole 15 (57.7)
Heel 3 (11.5)
Dorsum of foot 1 (3.8) 
Palm 0 (0)
Toenail 4 (15.5)
Fingernail 3 (11.5)
Total 26 (100)
cal stage IV were found to predict a poorer survival; hazard
ratios (HR) were 5.668 and 3.554 which were statistically
significant (Table 4). In the multivariate analysis, we eval-
uated the tumor thickness and clinical staging for genuine
decisive factors. An advanced clinical stage was shown to
be the most significant factor in predicting survival. The
HR was 3.264 for those with stage III and IV diseases (p <
0.05). Thickness remained in the model with a significant
HR of 2.167 (p < 0.05) (Table 4). The overall survival curve
was plotted according to the clinical stage (Fig. 2) and
there was a significant difference between stages I/II and
stages III/IV. The overall survival curve was also plotted
according to the treatment method for the melanomas of
hands and feet. There was no significant difference in the
survival rate between the patients treated by wide excision
and amputation (p = 0.39) (Fig. 3). 
Cutaneous melanoma is a rare disease in the non-Cauca-
sian populations, with an average annual age-adjusted inci-
dence of 1.0 per 100,000 persons in Asians.11 In Korea, the
incidence of malignant melanoma increased from 1.02%
of all skin malignancies in the 1980s to 15.6% in the 1990s.7,8
In Japan, malignant melanoma is the 3rd most common
cutaneous malignancy, representing 19% of all skin can-
cers.6 In our study, the incidence of malignant melanoma
was 0.073% which was similar to previous reports of inci-
dence (from 0.038% to 0.161%) of malignant melanoma in
Korea.7,12-14 The estimated annual percentage increase in
melanoma incidence of 6.1% was noted for Asians com-
pared to 5.0% for Caucasians, which suggests that melano-
ma is a cancer with an increase in its incidence in Asian
populations.11 Melanoma is known to affect young and
middle-aged people, unlike other solid tumors, which
mainly affect older adults. The median age at the diagnosis
of melanoma was 55.9 years in our study which was similar
to other studies.15 In Caucasian populations, males are
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DISCUSSION
Table 4. Univariate Analysis by Cox Proportional Hazard Model (Overall Survival)
Factor No. Hazard rate ratio 95% confidence interval p value
Age (yrs)
< 55 18 1
55 - 64 12 1.031 0.207 - 5.137 0.97
> 65 10 3.143 0.748 - 13.213 0.12
Sex
Female 22 1 - -
Male 18 0.876 0.261 - 2.946 0.83
Ulceration
Yes vs. No 9 / 40 0.442 0.129 - 1.516 0.193
Histologic subtype
SSM 2 0.821 0.157 - 10.309 0.821
LMM 5 0.995 - 0.995
ALM 26 1 - -
NM 7 0.978 0.216 - 4.838 0.978
Breslow level
< 2 mm 29 1 - -
≥ 2 mm 11 5.668 0.720 - 44.631 0.04
Stage
I 17 1 - -
II 18 1.583 0.04 - 2.79 0.709
III 4 2.127 0.34 - 6.35 0.995
IV 1 3.554 4.03 - 293.14 0.002
SSM, superficial spreading melanoma; LMM, lentigo maligna melanoma; ALM, acral lentiginous melanoma; NM, nodular melanoma.
Table 5. Multivariate Analysis by Cox Proportional Hazard 
Model (Overall Survival)
Factor Hazard rate ratio p value
Thickness (mm) 2.167 0.039
Stage
0 & I & II 1 -
III & IV 3.264 0.047
approximately 1.5 times more likely to develope melanoma
than females.15 The distribution of favored sites of occur-
rence is sex-dependent; the most common areas being the
back for men and the arms and legs for women.16,17 In our
study, there were more females diagnosed with melanoma
overall, and females predominated in cases of melanoma
occurring on hands and feet which corresponds to previous
reports.
There are many predictors of survival proposed accord-
ing to different stages. Tumor thickness determined by the
Breslow method and associated depth of invasion by Clark’s
classification have been reported to be the most important
independent prognostic variables in stage I, which includes
locally invasive melanoma.18-21 In our study, tumor thick-
ness (< 2 mm vs. > 2 mm) by univariate analysis and as a
continuous variable in multivariate analysis showed signi-
ficant difference in the prediction of survival. However,
when the thickness was evaluated by 4 mm, we did not
achieve a significant difference in prediction of survival
due to a small number of cases with thick melanomas. For
melanomas with regional metastases, the number of lymph
nodes positive for melanomas and the presence of extra-
nodal diseases were the most important prognostic factors
for survival.20,22 For melanomas with distant metastases, the
location of metastasis, presence of resectable metastatic
lesions, and duration of remission has all been shown to be
prognostic factors.19 Our study suggests that tumor thickness
and stage are the important predicting factors for melanoma
in Korean patients, with advanced stage being the more
significant of the two. Acral lentiginous melanoma is the
most common type in Asian populations.3,5,6 Our results
correlated with the previous reports in which the acral len-
tiginous melanoma was the most common histologic sub-
type compromising of 56.3% to 58.4%,12-14 and the sole was
the most common location. 
The risk factors for melanoma vary among ethnicity
ultraviolet radiation (UVR) exposures, specifically intense
early sunburns, are closely associated with the development
of melanoma in Caucasian patients.23-26 Other risk factors
for Caucasian patients include atypical and multiple nevi,
family or personal history of melanoma, intermittent sun
exposure, and Fitzpatrick skin types I and II.23-27 However,
UVR does not appear to be a significant risk factor for me-
lanoma in patients with darker skin color, who tend to de-
velop melanomas on non-sun-exposed areas such as palmar,
plantar, and mucosal surfaces.28 However, although less
significant than Caucasians, UVR still plays a role in the
development of melanomas in non-Caucasian population.
Several studies have shown evidence that migrant popula-
tion who move closer to the equator develop high rates of
melanoma compared to people in their country of origin.29-31
Some suggested that trauma may be a significant predispo-
sing factor for melanomas of hands and feet.32,33 However,
in our study, there were no patients with evident histories
of previous trauma on the sites of melanoma. The prog-
nostic significance of the anatomic site of origin remains
controversial. Many consider tumors that arise on the
palms, soles, and subungal locations to be particularly
ominous.34 However, Wells, et al.35 suggested that the dif-
ferences in outcome were largely explained by a difference
in tumor thickness at the time of diagnosis. Therefore, we
conducted our study in order to verify the prognostic signi-
ficance according to the anatomic locations in Korean pati-
ents. In our study, 65% of the melanoma was located on
the acral area (palm, sole and subungal area). However,
when compared with melanomas arising in other locations,
the age of patients at diagnosis, duration of lesions until
diagnosis, stage, presence of ulceration, and thickness of
tumor were not significantly different. Nor did the survival
rate significantly differ between the two groups. Our report
provides further evidence that melanomas arising in non-
Caucasian populations do indeed occur more frequently in
acral areas. However, melanomas occurring in acral areas
have a similar prognosis as those occurring in other areas. 
The standard therapy for primary cutaneous melanoma
is wide local excision. Current recommendations regarding
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Fig. 2. Survival curves by stages. Advanced stages had poorer prognosis (p <
0.05).
Fig. 3. Survival curves of melanoma in acral location by treatment method (p =
0.39).
the optimal surgical management of the primary mela-
noma are based on randomized clinical trials that princi-
pally have evaluated patients with cutaneous melanomas
of the trunk and extremities. Treatment of melanomas on
hands and feet is particularly challenging for the surgeons
due to the functional requirements of these body parts and
the difficulty of obtaining conventionally recommended
margins. Local recurrence rates have been reported to be
two to five times higher than those in other areas because
of the tendency to use smaller margins in treating lesions
of the hands and feet.36 Ever since Hutchinson first propa-
gated a radical surgical approach (amputation) for subun-
gal melanomas, this radical surgical strategy has been
recommended.37 However, amputations of the hands and
feet result in impaired function and cosmesis. Therefore,
moderate amputations were proposed to preserve the extre-
mities as long as possible without compromising safety
margins.36 Moehrle, et al.38 reported a recent experience
with “functional” surgery, avoiding amputation, and found
a similar incidence of local recurrence and improved survi-
val in the group of patients undergoing limited excision
compared with patients undergoing amputation. Our study
results also showed that the group treated by amputation
did not have a statistically significant survival benefit than
the group treated by local wide excision on melanomas of
hands and feet. However, in cases of subungal melanoma,
amputation is usually required due to the paucity of soft
tissue between the tumor and the bone beneath the nail.
Therefore, although amputation should not be recommend-
ed in general, it should be the first recommendation in cases
of subungal melanomas without enough safety margins. In
general, acral lentiginous melanomas are known to have
poorer prognosis due to a delay in diagnosis because of the
atypical locations and lack of awareness of this disease
entity in the non-Caucasian populations.39-41 However, our
study shows no difference in the prognosis of melanomas
of the hands and feet compared to melanomas of other
areas in Korean patients. Kato, et al.41 have observed im-
proved survival rates for patients with acral melanoma
during the last 22 years and attributed this improvement to
efforts by Japanese dermatologists to educate the general
public. Early detection programs impact the outcome of
melanoma. Therefore, increased educational efforts focus-
ing on populations’ anatomically distinct distribution of
primary sites should be made to increase the early and
accurate diagnosis of melanoma. 
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